850 related articles for article (PubMed ID: 16985029)
1. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction.
Chak A; Ochs-Balcom H; Falk G; Grady WM; Kinnard M; Willis JE; Elston R; Eng C
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1668-73. PubMed ID: 16985029
[TBL] [Abstract][Full Text] [Related]
2. Identification of Barrett's esophagus in relatives by endoscopic screening.
Chak A; Faulx A; Kinnard M; Brock W; Willis J; Wiesner GL; Parrado AR; Goddard KA
Am J Gastroenterol; 2004 Nov; 99(11):2107-14. PubMed ID: 15554988
[TBL] [Abstract][Full Text] [Related]
3. High risk of malignancy in familial Barrett's esophagus: presentation of one family.
Munitiz V; Parrilla P; Ortiz A; Martinez-de-Haro LF; Yelamos J; Molina J
J Clin Gastroenterol; 2008 Aug; 42(7):806-9. PubMed ID: 18385604
[TBL] [Abstract][Full Text] [Related]
4. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
[TBL] [Abstract][Full Text] [Related]
5. Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction.
Duhaylongsod FG; Wolfe WG
J Thorac Cardiovasc Surg; 1991 Jul; 102(1):36-41; discussion 41-2. PubMed ID: 2072727
[TBL] [Abstract][Full Text] [Related]
6. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
7. Barrett's esophagus and medications that relax the lower esophageal sphincter.
Corley DA; Levin TR; Habel LA; Buffler PA
Am J Gastroenterol; 2006 May; 101(5):937-44. PubMed ID: 16573773
[TBL] [Abstract][Full Text] [Related]
8. Barrett's esophagus: an acquired condition with genetic predisposition.
Fahmy N; King JF
Am J Gastroenterol; 1993 Aug; 88(8):1262-5. PubMed ID: 8338095
[TBL] [Abstract][Full Text] [Related]
9. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
[TBL] [Abstract][Full Text] [Related]
10. Barrett's esophagus and risk of esophageal adenocarcinoma.
Cossentino MJ; Wong RK
Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
[TBL] [Abstract][Full Text] [Related]
11. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
[TBL] [Abstract][Full Text] [Related]
12. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma in Barrett's esophagus after elimination of gastroesophageal reflux.
Hamilton SR; Hutcheon DF; Ravich WJ; Cameron JL; Paulson M
Gastroenterology; 1984 Feb; 86(2):356-60. PubMed ID: 6690363
[TBL] [Abstract][Full Text] [Related]
15. Barrett's esophagus: prevalence in symptomatic relatives.
Romero Y; Cameron AJ; Schaid DJ; McDonnell SK; Burgart LJ; Hardtke CL; Murray JA; Locke GR
Am J Gastroenterol; 2002 May; 97(5):1127-32. PubMed ID: 12017151
[TBL] [Abstract][Full Text] [Related]
16. Familial Barrett esophagus and adenocarcinoma of the gastroesophageal junction.
Eng C; Spechler SJ; Ruben R; Li FP
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):397-9. PubMed ID: 8348064
[TBL] [Abstract][Full Text] [Related]
17. [Association between symptomatic gastroesophageal reflux and Barrett's esophagus].
Trujillo-Benavides OE; Baltazar-Montúfar P; Angeles-Garay U; Ramírez-Mendoza P; Navarro-García AM; Paredes-Cruz E; Méndez del Monte R; Guerrero-Hernández M
Rev Gastroenterol Mex; 2005; 70(1):14-9. PubMed ID: 16170957
[TBL] [Abstract][Full Text] [Related]
18. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study.
Bytzer P; Christensen PB; Damkier P; Vinding K; Seersholm N
Am J Gastroenterol; 1999 Jan; 94(1):86-91. PubMed ID: 9934736
[TBL] [Abstract][Full Text] [Related]
19. Familial clustering of reflux symptoms.
Trudgill NJ; Kapur KC; Riley SA
Am J Gastroenterol; 1999 May; 94(5):1172-8. PubMed ID: 10235188
[TBL] [Abstract][Full Text] [Related]
20. Prediction of malignant potential in reflux disease: are cytokine polymorphisms important?
Gough MD; Ackroyd R; Majeed AW; Bird NC
Am J Gastroenterol; 2005 May; 100(5):1012-8. PubMed ID: 15842572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]